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ABSTRACT OF THESIS   
MODULATION OF VACCINE-INDUCED RESPONSES 
BY ANTHELMINTIC TREATMENT IN PONIES  
Vaccines and anthelmintics induce an inflammatory response in equids. Since they are 
commonly given concurrently, it is practical to study any interaction between them. This 
study evaluated whether IVM and PYR would modulate the acute phase inflammatory 
response, the systemic gene expression of pro-inflammatory cytokines, and vaccine-
specific titers induced by WNV, EHV, and KLH vaccines. Naturally-infected, yearling 
ponies were sorted by gender, then fecal epgs. They were randomly assigned to three 
treatment groups: IVM, PYR, and control. All ponies received vaccinations 
intramuscularly on days 0 and 29. Whole blood, serum, and plasma samples were 
collected 1, 3, and 14 days post-vaccination. Samples were analyzed for inflammatory 
markers, cytokine, mRNA expression, and vaccine-specific IgG titers by ELISA. The 
acute-phase inflammatory marker data showed no statistical significance; they did show 
an increase in SAA, haptoglobin, and fibrinogen, and a decrease in iron after vaccination. 
The mRNA data showed that anthelmintics had a significant effect on interleukin mRNA 
levels, but not on TNF- or IFN- levels. The ELISA assays showed no biologically 
significant reduction in IgG as compared to the control group. We conclude that 
deworming does not affect vaccine IgG titers; therefore, ceasing vaccinating and 
deworming concurrently is not necessary.  
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1. Introduction  
Intestinal invertebrate parasites of the horse, known as helminths, can alter the 
immune response both locally and systemically (Betancourt et al. 2014, Davidson et al. 
2005). Drugs targeting these multicellular organisms are known as anthelmintics; they are 
commonly given to horses on the same day as routine vaccinations, such as for West Nile 
virus and equine herpes rhinopneumonitis virus. Both anthelmintics and vaccines are 
known to induce inflammation in horses (Steinbach et al. 2006, Andersen et al. 2012), 
but studies into the effect of deworming on the systemic inflammatory response induced 
by the vaccines has not been extensively studied.                                     
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2. Background 
Helminths are parasites that can be characterized into three main phyla: 
Platyhelminthes (flukes and tapeworms) Nematoda (roundworms) and Acanthocephala 
(thorny-headed worms) (Castro 1996). This thesis concentrates on the equine intestinal 
nematode parasites known as the strongyles (order Strongylida), the largest order of 
parasitic helminths in horses. The adults of family Strongylidae are identified by a well-
developed buccal capsule and a copulatory bursa (Lichtenfels 1975). The adults can range 
from 5 mm to 4.5 cm in length, with the males being smaller than the females 
(Reinemeyer et al. 2007, Taylor et al. 2013). The family Strongylidae is further divided 
into two subfamilies: the Strongylinae (large strongyles) and the Cyathostominae (small 
strongyles), differentiated using the shape of their buccal capsule. The Strongylinae have 
a funnel-shaped buccal capsule, while Cyathostominae have a cylindrical buccal capsule 
(Lichtenfels 2008). The focus of the study described herein is the family Cyathostominae.  
2.1 Cyathostominae 
The cyathostomins are a family consisting of 13 morphologically different genera 
that contain 51 species in total; 40 of these species are found in horses and ponies, while 
the other 11 are only found in other equids (Lichtenfels et al. 2008). They are 
microscopically similar to the large strongyles at their early stages (egg, first two larval 
stages), but can be differentiated from the other Strongylida by their internal morphology 
once they reach the third infective larval stage (Figure 1).   
2.2 Life cycle 
Strongyle eggs are excreted from the horse via the feces, where they develop into 
the first three larval stages (L1, L2, and L3) in the environment (Figure 2). Once the third 
infective larval stage (L3) on the pasture is ingested by the horse, it penetrates into the 
mucosal layer of the large intestine, where it develops into the early third larval stage 
(EL3), late third larval stage (LL3) then the fourth larval stage (L4) and sometimes early 
fifth stage (L5) before exiting the mucosa and developing into reproductive adults. The 
exit of the cyathostomins into the intestinal lumen causes an inflammatory response, 
Figure 2.1- A third infective larval 
stage of a cyathostomin; note the 8 
intestinal cells, the sheath, the long 
tail and the filariform esophagus.
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exacerbated if the encysted stages (EL3, LL3 and L4) are induced to exit the mucosa by 
the administration of fenbendazole (see section 2.4). The entire process from L3 ingestion 
to finding eggs in the feces, also known as the prepatent period, ranges from six to eight 
weeks for the first maturing species, if not interrupted by arrestment of EL3s (Ihler 2010, 
Lyons 2011). Classification of the different stages is by morphology and location of the 
stage, which is most efficient if the horse is necropsied. In this thesis, we will be 
identifying the different strongyle species via microscopic observation of third-stage 
larvae (Appendix B). Identification of the different species of strongyle is necessary to 
determine the correct treatment regimen. 
2.2.1. Effects of encysted L3 and L4 stages on the intestinal mucosa 
The free-living L3 stage is able to survive on pasture for several months at a time; 
once inside the horse, the EL3 stage can arrest within the mucosal tissue of the cecum 
and ventral colon, emerging as early as one month and as late as three years after arrest. 
(Gibson 1953, Reinemeyer and Nielsen 2012). In northern temperate climates of the U.S., 
the LL3s encyst in the mucosa in the fall, develop into L4s within the cyst over the 
winter, and then emerge in the spring (Reinemeyer 1986). In most cases, these L4s 
emerge from the mucosa into the lumen a small fraction of the population at a time, 
causing diffuse necrotic swellings (Love et al. 1999). 
         
Figure 2.2- Cyathostomin life cycle. Clockwise from (a) to (h): egg, larvated egg, L1, 
L2, L3, EL3, L4, adult.
(a) 
(b) 
(c) (d) 
(e) 
(f) 
(g) 
(h) 
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If large numbers of larvae emerge synchronously, this causes mucosal cell rupture 
accompanied by loss of fluid and proteins into the lumen, also known as protein-losing 
enteropathy (Lyons et al. 1999, Steinbach et al. 2006). This greater damage causes a 
massive inflammatory reaction in the mucosa, along with intestinal lesions. These effects, 
in turn, can cause chronic diarrhea (Love et al. 1999, Peregrine et al. 2005). This 
condition, called larval cyathostomiasis, can be severe enough to cause death of the horse 
(Love et al. 1999). Although some horses may present with symptoms in the clinic, most 
infected horses are asymptomatic. 
Although a horse may not exhibit visible symptoms, an infection with 
cyathostomins can cause hematological changes; in highly parasitized horses, these 
changes can include low neutrophil counts, low serum albumin levels, anemia, and high 
-globulin (Love et al. 1999). In addition, the horse will exhibit local cytokine release 
associated with Th2 (IL-4 and IL-10) and Th1 (IFN- and TNF ) responses (Davidson et 
al. 2005), with Th2 being the predominant response with non-filarial parasites. The Th1 
response is more associated with the killing of intracellular pathogens and is involved 
with the vaccine response (Berger 2000).  
2.3. Anthelmintic types 
Anthelmintics are classified based on their subcellular targets in the parasite. 
Three different classes of anthelmintics are approved for use in equids to treat strongyles 
in the United States: macrocyclic lactones, tetrahydropyrimidines, and benzimidazoles 
(Holden-Dye and Walker 2007). We can test the efficacy of these compounds using the 
equation in section 3.2. 
2.3.1. Macrocyclic lactones  
Macrocyclic lactones (MLs) such as ivermectin (IVM) and moxidectin (MOX) are 
used to treat cyathostomin infections by paralyzing the body wall muscles of the worm, 
specifically causing flaccid paralysis (Holden-Dye and Walker 2007, Claerebout and 
Vercruysse 2012a). This paralysis is caused by the interaction of the drug with several 
ligand-gated ion channels including nicotinic acetylcholine (nACh) receptors, ACh-gated 
chloride channels, GABA-gated chloride channels, and histamine-gated chloride 
channels. Of these various channels, it is their strong interaction with glutamate-gated 
chloride channels that is the main method of action of the macrocyclic lactones (Holden-
Dye and Walker 2007). The paralyzed worm is then passed out of the horse via normal 
peristalsis (Claerebout and Vercruysse 2012b). MLs are generally effective against 
strongyles, but ascarids currently are mostly resistant to this class of drugs (Peregrine et 
al. 2014). The current efficacy of a single dose of ivermectin (0.2 mg/kg IVM) against 
strongyles in some studies is between 89% and 100% (Canever et al. 2013, Lester et al. 
2013, Relf et al. 2014, Stratford et al. 2014). However, there are recent reports of reduced 
activity of IVM and MOX against small strongyles in horses in several geographical sites 
(Demeulenaere et al. 1997, Costa et al. 1998, Traversa et al. 2009, Lyons et al. 2011). 
This is based on finding earlier returns of epgs after treatment compared initial activity 
when MLs were first marketed. Critical tests recently have shown that activity on adult 
small strongyles was still high but less on immature intestinal luminal stages; the result 
being that the life cycle is shortened (Lyons et al. 2009).  
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2.3.2. Tetrahydropyrimidines  
Pyrantel pamoate (PYR) and pyrantel tartrate act as excitatory nACh receptor 
agonists in the muscles lining the body wall of the small strongyle (Holden-Dye and 
Walker 2007, Alverez et al. 2009). As an agonist, the drug binds competitively to the 
nACh receptor and over-activates it. As a result, pyrantel causes spastic paralysis 
(Holden-Dye and Walker 2007). As with the macrocyclic lactones, the paralyzed worm is 
then passed out of the horse via normal peristalsis (Claerebout and Vercruysse 2012b). 
Strongyles have a large range of resistance to pyrantel, with current single-dose (19 
mg/kg) efficacy between 50% and 100% (Canever et al. 2013, Hsu and Martin 2013, 
Lester et al. 2013, Relf et al. 2014, Stratford et al. 2014). 
2.3.3. Benzimidazoles 
Benzimidazoles affect the microtubular cytoskeleton of the parasite by binding to 
-tubulin. This causes impaired movement and impaired reproductive ability of the 
parasite (Holden-Dye and Walker 2007). Fenbendazole, the only benzimidazole approved 
for larvicidal use globally, needs to be given at higher doses to eliminate those 
cyathostomins which are encysted in the large intestinal mucosa (Claerebout and 
Vercruysse 2012c). Currently, fenbendazole has between 0% and 84% efficacy against 
luminal strongyles when given as a single dose (Canever et al. 2013, Lester et al. 2013, 
Relf et al. 2014, Stratford et al. 2014). Unfortunately, when fenbendazole is given to a 
horse in the larvicidal dose (10 mg/kg for 5 days), it triggers a local response by T 
lymphocytes, eosinophils and macrophages, which surround L3 and L4 cyathostomins in 
a thick granuloma. Within 4 to 6 days after fenbendazole treatment, the encysted larvae 
die, releasing nematode waste products, to which intestinal eosinophils and lymphocytes 
react, causing localized edema (Love et al. 1999). Within 2 weeks of treatment with the 
larvicidal dose, morphological changes to the large intestine, including ulceration and 
erosions into the mucosa, appear; these lesions can extend into the bowel wall (Steinbach 
et al. 2006).  
2.4. Intestinal response to anthelmintic treatment in the horse 
Though anthelmintics are a necessary part of parasite control in the equid, they 
can also trigger adverse reactions in the intestine as the adults are killed. These adverse 
reactions include weight loss, diarrhea, subcutaneous edema and fever, a condition 
known as larval cyathostomiasis (Love et al. 1999). In a study by Reid et al. (1995), they 
used several statistical methods (student s t test, chi-square test and multiple logistic 
regression analysis) to find the variables most likely to contribute to chronic diarrhea, 
which they classified as larval cyathostomiasis; the effect of time since last anthelmintic 
treatment (i.e. less than 2 weeks gave a higher score than anthelmintics given more 
than two weeks prior to admittance to an equine hospital) was a significant contributor 
(P=0.02) to the development of larval cyathostomiasis. The only other factors which were 
of equal or higher significance were age (P=0.001) and season of diagnosis (P=0.02) 
(Reid et al. 1995).  
2.5. Anthelmintic resistance and herd management 
The FDA defines anthelmintic resistance as the ability of a subset of parasites to 
survive treatment with a specific anthelmintic to which they were previously susceptible 
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(USFDA-CVM 2013a). This phenomenon is due to changes in their genome and that of 
their descendants. Resistance is determined by several factors, including the immune 
status of the host animal and treatment protocols (USFDA-CVM 2013a). With regard to 
detecting efficacy of the drug in a specific herd and therefore the level of parasite 
resistance to the drug a fecal egg count reduction test (FECRT) is performed. The test 
is performed on data taken from a group of animals and involves the calculation of the 
percent reduction in the number of parasite eggs in a fecal sample between Day 0 and 
Day 14 after treatment (USFDA-CVM 2013b). As recommended by Stratford et al. 
(2014), any FECR found to be less than 90% indicates resistance is developing, or has 
already developed, to the drug.  
2.6. Immune modulation and inflammatory response to helminths 
In humans, infecting parasites, such as Strongyloides stercoralis, induce 
inflammation by releasing pathogen-associated molecular patterns (PAMPS). The PAMPs 
regulate transcriptional activation of tumor necrosis factor (TNF- ), interleukin-1 (IL-1), 
and interleukin-6 (IL-6), all of which are pro-inflammatory cytokines. If chronically 
present, they can cause ulcerative colitis and inflammatory bowel disease (Berridge 2012, 
Romero-Cabello et al. 2012). 
Infection of helminths into tissues causes the initiation of the type 2 helper T cell 
(Th2) inflammatory response; this response involves the recruitment and activation of 
basophils, eosinophils, and mast cells (shown in Figure 3) (Koyasu and Moro 2011). Th2 
cells are one of three types of CD4+ helper T cells; the other categories are the type 1 
helper T  (Th1) and type 17 helper T (Th17) cells (Zhu et al. 2010). Anti-inflammatory 
cytokines, such as interleukin-25 and interleukin-33 (IL-25 and IL-33), are produced in 
response to helminth infection by epithelial cells in the intestine. Their role is to induce 
the blockage of helminth invasion of the mucosa until an adaptive response can be 
initiated. In addition, IL-4 is produced by basophils and mast cells when stimulated by 
the invading parasite and IL-6 is produced constitutively by natural helper cells, causing 
antibody production and iron sequestration (Koyasu and Moro 2011). 
Levels of non-heme iron transported by ferritin in the blood are used as marker of 
inflammation by veterinary and human clinicians; when an inflammatory stress response 
is triggered by the secretion of IL-6, it, in turn, induces the upregulation of the hormone 
hepcidin. Hepcidin is a peptide that binds to an iron transport protein, ferroportin, in the 
intestinal mucosa. When hepcidin is upregulated, ferroportin is downregulated, causing 
iron withdrawal from the body and its subsequent sequestration, causing anemia (Johnson 
and Wessling-Resnick 2012). In addition, this sequestration of iron restricts the parasites 
access to the element, which is important in the function of redox enzymes, such as 
NADH-fumerate reductase (NFR). This enzyme contains an iron-sulfur cluster as the 
catalytic center and is responsible for the conversion of fumarate to succinate in the 
helminth respiratory chain (Omura et al. 2001, Johnson and Wessling-Resnick 2012). 
Helminth infection is known to block Th1 response activation, and instead 
induces the activation of the Th2 response in rodents and immunocompromised humans 
(Peón et al. 2013). The Th1 response is normally associated with infectious diseases 
because of its induction of IFN-gamma (IFN- ) and tumor necrosis factor alpha (TNF- ) 
(Figure 3), which in turn stimulates phagocytosis and oxidative burst, as well as antigen 
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presentation to cytotoxic T cells (Spellberg and Edwards 2001, Davidson et al. 2005). In 
contrast, Th2 responses are associated with IL-4 and IL-10 and cause antibody 
production, B cell proliferation, and infiltration of eosinophils and basophils into the 
tissues; this action leads to a more allergic response (Spellberg and Edwards 2001, 
Davidson et al. 2005). 
Davidson et al. (2005) published a study which explains the inflammatory 
response to cyathostomins with regard to cytokine levels in naturally-infected horses. 
Similar to aspects of the study described in this thesis, these cytokines were measured by 
reverse transcriptase-competitive PCR (RT-cPCR) using the method described by 
Guiguère and Prescott (1999). The reaction products were run on an agarose gel, and then 
measured using densitometry, from which standard curves were graphed. All values were 
normalized to -actin levels and expressed as fold change in cytokine mRNA expression 
(Guiguère and Prescott 1999). However, unlike our study, Davidson et al. measured local 
inflammation by taking mucosal samples of 6 sites in the intestine and measuring 
cytokine and encysted larval burdens for each sample for all 17 horses. The study found 
that increased IL-10 and IL-4 levels, therefore Th2 responses, are linked to the presence 
of cyathostomins in the large intestinal wall, while IFN- was not associated with larval 
parasite burdens. TNF- was only seen in those areas of the excised intestine which had 
signs of mass excystment and/or empty cysts (Davidson et al. 2005). 
Helminths, such as Schistosoma spp. and Trichinella spp., have been found to 
modulate Th1 inflammatory responses in rodent and human subjects (Mangan et al. 2004, 
McKay 2009, Walsh et al. 2009, Harn et al. 2009,  Osborne et al. 2014); prior to the 
current study, the modulation of inflammation by helminths in the horse has not been 
studied. Previous studies in mice noted that interleukin-10 (IL-10) was the main cytokine 
that contributed to protection against the Th2 response induced by infection (Mangan et 
al. 2004, McKay 2009). For example, Mangan et al. (2004) found that Schistosoma 
mansoni can induce the proliferation of B cells producing IL-10, which protects mice 
from severe anaphylaxis. In a recent study by Osborne et al. (2014), they examined 
whether Trichinella spiralis modulates the murine immune system by direct interaction or 
by perturbing the natural gut microbiota. They found that a Type 2 T cell response was 
induced and that the cytotoxic T cells specific to the virus given were not only decreased 
in number, but also reduced in their effector functionality (i.e. stimulating the caspase 
cascade leading to apoptosis of the target cell) when coinfected with the parasite (Harty et 
al. 2000). In addition, they found that the helminths directly regulate antiviral T cell 
responses, which could affect the efficacy of vaccines (Osborne et al. 2014). 
Due to the helminths' ability to decrease inflammatory reactions in the intestine, 
live helminths and helminth-derived proteins, such as those from Trichinella spp. have 
been used therapeutically to decrease inflammation associated with inflammatory bowel 
diseases, such as Crohn s (Motomura et al. 2008, Chu et al. 2013, Sandborn et al. 2013, 
Hiemstra et al. 2014). Ironically, in addition to the helminths controlling the 
inflammatory response in the intestine, one of the anthelmintic drugs used in these 
studies, ivermectin, suppresses inflammation in rodent models by decreasing 
immunoglobulin G (IgG) and decreasing infiltration of neutrophils, lymphocytes and 
macrophages leading to a decrease in allergic inflammation, i.e. decreasing the Th2 
response (Yan et al. 2011). 
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When the immune response is differentiated toward a Th2-type response during 
helminth infection, B cells begin to produce immunoglobulin E (IgE) and 
immunoglobulin G (IgG) in response to the release of IL-5 by eosinophils (Harris and 
Gause 2011). 
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Figure 2.3- The adaptive immune response to helminth infection with the pertinent cytokines and acute phase 
proteins. Colored labels are the acute inflammatory markers commonly used in the veterinary clinic; the positive 
signs mean that when inflammation is present, the systemic levels of these factors increase, while systemic iron 
decreases with inflammation. Cytokines involved in the TH2 response are shown in red font; those which are 
involved in the T H1 response are shown in green. Immune cells are shown in dark blue. Sources: Gause et al. 2013, 
Koyasu and Moro 2011. 
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2.6.1. Acute inflammatory response to vaccination 
Acute-phase proteins (APPs) are serum proteins originating in the liver that can 
be used as a measure of levels of inflammation or infection (Eckersall 1995). The panel 
of APPs used in quantification of the inflammatory response in the clinic is haptoglobin, 
fibrinogen, and serum amyloid A (SAA). In addition to these three proteins, it is also 
common to test serum iron levels as a marker of inflammation.  
In a study by Andersen et al. (2012), ten horses were given, intramuscularly, an 
immune stimulating complex (ISCOM) vaccine, specifically an inactivated 
influenza/tetanus toxoid vaccine, or an adjuvanted, live recombinant vector vaccine 
containing two influenza strains and tetanus toxoid. They found that serum SAA and 
fibrinogen levels increased within 24 hours of injection with both vaccines, with elevated 
inflammatory marker levels throughout the 96-hour study. As would be expected with the 
SAA and fibrinogen level increases, there was a decrease in serum iron levels for 48 
hours post-vaccination with both vaccines. Overall, the ISCOM vaccine gave a higher 
inflammatory response than the vector vaccine. They concluded that vaccination is a 
viable inducer of mild inflammation in the horse for study of the acute phase response. 
2.6.2. Cytokine expression in response to vaccination  
In addition to monitoring the inflammatory markers mentioned above, 
inflammation can be monitored via leukocyte-produced cytokine levels and 
hematological properties. The cytokines associated with the inflammatory Th2 vaccine 
response in the horse are IL-4, IL-5, and IL-10, while IL-2, IFN- and TNF- are released 
by Th1 cells after vaccination (Romagnani 1999). With the EHV vaccine we would 
expect to see an increase in blood levels of IL-4, IL-5 and IL-10, while the WNV vaccine 
would induce IFN- and/or TNF- release. The cytokines measured in this study (IL-1 , 
IL-4, IL-10, TNF- and IFN- ) are released at the highest level between at about 10 and 
about 56 days after vaccination (Paillot et al. 2005, Kydd et al. 2006). 
2.6.3. Hematological effects of vaccine and measuring vaccine antibody titers  
Adjuvanted vaccines, such as the EHV and WNV vaccines in this study, or the 
ISCOM vaccine in the Andersen et al. study described above, cause increases in total 
WBC count, while protein vaccines have less of an effect on WBC levels (Andersen et al. 
2012). 
In addition to measuring cytokine levels and hematological features, the response 
of the host immune system to the vaccine can be directly measured via antibody titers, 
specifically different isotypes of IgG.   
Four isotypes of IgG are commonly found in horse serum: IgG(a), IgG(b), IgG(c), 
and IgG(T). IgG(a) and IgG(b) act via complement activation and opsonization (i.e. they 
are cytophilic antibodies) and are associated with an acute inflammatory vaccine 
response, while IgG(c) and IgG(T) act via competing with IgG(a) and IgG(b) for 
antigens, with IgG(T) being associated with a more chronic inflammatory vaccine 
response. Production of IgG(a) and IgG(b) is induced by the release of IFN- by Th1 
cells, IgG(c) is associated with respiratory burst by peripheral leukocytes, and IgG(T) 
release occurs with the end of active infection (Cunha et al. 2006, Lewis et al. 2008). 
When vaccinated, IgG isotypes appear in the serum at different times post-inoculation: 
IgG(c) appears first, IgG(a) appears at approximately 1 week, IgG(b) at approximately 3 
weeks, and IgG(T) appears only after acute infection resolves, between 4 and 16 weeks 
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post-inoculation (Cunha et al. 2006). 
2.6.4. Modulation of inflammation by helminths and by anthelmintics 
It is well established in large animals, both ruminant and horse, that vaccination 
causes a potent inflammatory response, but modulation of this inflammatory response by 
anthelmintics in horses is not as well defined (Killi 2008, Hepburn et al. 2009, Andersen 
et al. 2012). 
A recent study on the subject of modulation of inflammation by anthelmintics was 
performed in calves (Schutz et al. 2012). They measured IL-4, IL-6, TNF- , and IFN- 
levels in calves after treatment with fenbendazole at one of two time points: 2 weeks pre-
vaccination or at same time as vaccination. Another group of calves was given no 
anthelmintic treatment but was vaccinated. When the calves were given the deworming at 
the same time as they were vaccinated, there was a suppression by treatment on Th2 
cytokine levels, specifically IL-4 levels. In addition, there was a decrease in parasite 
burden. The decrease in Th1 response could influence the efficacy of the response against 
repeat viral infection, i.e. decreased vaccine efficacy (Schutz et al. 2012). If this is true in 
horses, then the vaccine efficacy should decrease with anthelmintic treatment. 
The only previous study looking into the effect of removal of helminths on the 
vaccination response in equids was published in 2001 by Edmonds et al. The study was 
performed by dosing naturally-infected ponies with pyrantel pamoate (two doses, three 
weeks apart) or moxidectin (one dose). Twenty-four days after the first treatment of 
pyrantel or the dose of moxidectin, keyhole limpet hemocyanin (2 mg) was injected i.m. 
Pre-treatment, 2 weeks and 4 weeks post-treatment blood samples were taken in order to 
determine cytokine (IL-2, IL-4, IL-5, and IFN- ) and vaccine-induced antibody (IgA, 
IgG(a), IgG(b), and IgG(T)) levels, and to determine the peripheral blood mononuclear 
cell (PBMC) proliferation in response to two different stimulants (KLH and pokeweed 
mitogen).The proliferation was measured as the mean count per minute for the stimulated 
versus the unstimulated cells. At 4 weeks, the ponies were euthanized, and necropsied in 
order to recover parasites (large and small strongyles, ascarids, and fly larvae) for 
characterization and enumeration. They found that the parasitism level did affect the 
KLH-induced cytokine response by PBMCs; ponies with fewer parasites had higher IL-4 
and IFN- levels as compared to the non-vaccinated and heavily parasitized or the KLH-
vaccinated and moderately-to-highly parasitized ponies. There was no statistical 
significance to the KLH-specific Ig levels, but the trend seemed to lean toward low 
parasite-burdened ponies having higher total Ig and IgA levels at both two and four 
weeks post-vaccination, while IgG(T) levels were higher for the less parasitized ponies at 
two weeks only (Edmonds et al. 2001). These results suggest that removal of helminths, 
as an effect of treatment, could increase the effectiveness of a vaccine when the horse is 
challenged. 
2.6.5. Parasite dynamic changes with equine host age  
It has been established that the proportions of cyathostomin stages change as the 
horse matures. As horses age, the production of pro-inflammatory cytokines such as IFN- 
and TNF- increase in the peripheral blood (Adams et al. 2008, Hansen et al. 2013). 
One previous study performed by Katepalli et al. (2008) used radioactive thymidine 
incorporation to test the hypothesis that as horse telomeres shorten with PBMC division, 
there will be a decline in immune function. They confirmed this hypothesis by finding 
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that as telomeres shorten in PBMCs, the total serum IgG decreased and pro-inflammatory 
cytokine expression increased. 
Prior to the study by Katepalli, Chapman et al. (2003) studied the prevalence and 
amount of cyathostomins in a range of ages of ponies. Previously untreated ponies 
between the ages of 4 months and 5 years were naturally infected and fecal egg counts 
were taken. At various times of the year, these ponies were necropsied and cyathostomins 
were enumerated and classified as EL3, developing third stages in the mucosa, early 
fourth stages still encysted in mucosa, luminal L4s or adults. The results showed that the 
group with the highest percentage of EL3s was the 2 year olds, the L4s tended to make up 
the highest percentage of cyathostomins in the 3 to 5 year-old pony lumens, and 1 year 
olds had the highest number of adults in their intestinal lumen. The percentage of DLs 
was, after considering the standard deviation, the same in all three age groups.  
2.7 Knowledge gaps and how we fill them 
Before this study, there were no studies which evaluated how the vaccination 
response could be affected by the use of anthelmintics; this is a concern because foals are 
commonly vaccinated and dewormed monthly for the first 12 months of life, with the 
vaccinations and deworming occurring on the same day. In addition, as Th1 responses are 
the selected for with most infections, and therefore vaccines, while deworming would 
cause a shift toward a Th2 response (Nielsen et al. 2013). It is the aim of this study to 
determine whether there is an interaction between the vaccine-induced inflammation and 
the anthelmintic-induced inflammation which could affect vaccine response, either 
increasing or decreasing that response.                       
 14  
3. Experimental methodology 
3.1 Aims and hypotheses 
The study's main hypothesis is that any inflammation caused by vaccination, and 
the vaccine efficacy, will be modulated by the administration of a concomitant 
anthelmintic treatment. To test this hypothesis, we analyzed acute phase proteins and 
cytokines in response to a combination of vaccinations, and, simultaneously, compared 
the impact of the two anthelmintics on the vaccine response using ELISAs, inflammatory 
markers, hematology and cytokine analyses. 
Over 60 days in August and September 2013, a total of 23 female and intact male 
ponies of approximately 8 months of age were involved in the study. The treatment 
protocol included vaccination of all ponies with three separate vaccines: a protein vaccine 
without adjuvant (keyhole limpet hematocyanin, KLH; 10 mg/kg for first dose, 5 mg/kg 
for subsequent dose; Sigma, Saint Louis, MO), a live recombinant, adjuvanted vaccine 
(West Nile virus, WNV; Recombitek rWNV, Merial; 1 mL/dose), and an inactivated viral 
vaccine containing an Carbomer adjuvant (equine herpes rhinopneumonitis, EHV; 
Prodigy with Havlogen, monovalent, Merck Animal Health; 2 mL/dose). Before 
administration of vaccines and anthelmintics, the ponies were weighed using a platform 
scale (model #700, Tru-Test Inc., Mineral Wells, TX). All vaccines were given i.m, and 
each vaccine was given in one of three locations: the left side of the neck, the right side 
of the neck and the pectoral region. All ponies were dosed two times, four weeks apart 
with the vaccines. Concurrently, one cohort received, per oral, ivermectin (IVM; 
Eqvalan, Merial; 200 g/kg, 8 ponies, Group A), a second received pyrantel pamoate 
(PYR; Strongid Paste, Pfizer Animal Health; 6.6 mg base/kg, 8 ponies, Group B), and the 
third cohort were kept untreated (Control, 7 ponies, Group C). At various time points 
after each vaccination and anthelmintic treatment, we took blood and fecal samples from 
all ponies. Blood was taken in order to analyze cytokine RNA levels (Tempus, Life 
Technologies), inflammatory marker levels (BD Vacutainer® for serum, BD 
Technologies, Durham, NC), to run vaccine titer analyses (BD Vacutainer® Plus Citrate 
Tubes, BD Technologies, Durham, NC), and to do hematological counts (BD 
Vacutainer® Plus K2 EDTA Tubes, BD Technologies, Durham, NC), such as white blood 
cell counts, hematocrit and leukocyte subtyping.  Feces were collected in order to find the 
efficacy of the two anthelmintics in this cohort of ponies. The treatment and testing 
protocols are displayed in Table 1. 
Table 3.1-Experimental protocol by day number. "X" indicates the action taken that day.  
Day 
-4 0 1 3 4 14 21 29 30 32 35 42 50 59 
Vaccines  x      x       
Anthelmintics  x      x       
Whole blood x* x x x x x  x x x  x   
Feces x x    x x x   x x x x
* On this day, only serum was taken.  
3.2 Egg counts 
In order to quantify efficacy of the two anthelmintics in the horses, fecal egg 
counts (FECs) were performed. Feces were collected on the experimental days shown in 
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Table 1. The sampling at Day -4 was performed in order to determine groupings for 
dosing of the anthelmintics (see section 3.2 for more detail). Using the mini-FLOTAC 
method, we were able to find the egg count per gram with a sensitivity of 5 eggs per gram 
(epg) (Barda et al. 2013, Cringoli et al. 2010) (Figure 4; for further details, please see 
Appendix A). After all counts were performed for all time points, a fecal egg count 
reduction test (FECRT) was calculated against the pre-treatment counts for the strongyles 
using the equation  
FECR= 100*(FECDay 0 - FECDay 14)/FECDay 0 
to determine the efficacy of the anthelmintics in each individual in the treatment groups 
versus the ponies in the control group.  
In addition to the FECs, the eggs were characterized based on morphology (i.e. 
strongyle eggs were differentiated from ascarid and tapeworm eggs) (Zajac and Conboy 
2012).                    
3.3 Selection of groups 
Grouping of ponies for treatment was based on the epg for Day -4 samples. The 
ponies were sorted first by gender and then ranked by descending eggs per gram, i.e. have 
equal numbers of low, medium, and high egg shedders in each group. After these 
parameters were satisfied, the ponies were allocated to each group (1st pony was put into 
group 1, the second was put into group 2, the third into group 3, etc.) The range of epg 
was between 35 and 1725 strongyles. The anthelmintic type and distribution were as 
follows (female, male): IVM (4,4); PYR (4,4) and Control (4,3).  
3.4. Hematology 
All hematological assays were performed by the University of Kentucky 
Veterinary Diagnostic Laboratory. The following hematology tests were measured on 
samples collected on the dates shown in Table 1: white blood cell (WBC) and red blood 
Figure 3.1. Setup of mini-FLOTAC 
apparatus. Picture from Barda et al. 
(2013). 
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cell (RBC) counts, percentage of leukocytes (neutrophils, lymphocytes, basophils, and 
monocytes), hematocrit, hemoglobin levels, and other RBC characteristics (mean 
corpuscular hemoglobin, mean corpuscular volume, and mean corpuscular concentration) 
using a Forcyte hematology analyzer (Oxford Science Inc., Oxford, CT).  
3.5. Inflammatory markers 
All inflammatory markers were measured using automated spectrophotometric 
methods in the laboratory of Dr. Stine Jacobsen (Univ. of Copenhagen). Serum amyloid A 
levels were measured using an immunoturbidometric assay (LZ SAA EIKEN, 
EIKEN Chemical Co., Ltd., Shanghai, China), haptoglobin levels were measured using a 
peroxidase assay (Phase Range Hp Assay, Tridelta Development, Ltd., Maynooth, 
Ireland), fibrinogen levels were measured using the Clauss method on an automated 
coagulometric analyzer, and iron levels were measured by colorimetric 
spectrophotometry (ADVIA 1650, Siemens Healthcare, Erlangen, Germany) (Andersen 
et al. 2014, Jacobsen et al. 2005a).  
3.6. Cytokine expression 
Blood was collected via venipuncture into Tempus tubes (Life Technologies, 
Grand Island, NY) on the days outlined in Table 1. The samples were analyzed by 
Alejandra Betancourt (Gluck Equine Research Center). RNA isolation was performed 
using an iPrep Purification Instrument (Life Technologies, Grand Island, NY) and the 
Purelink RNA isolation kit (Life Technologies, Grand Island, NY) as per the 
manufacturer s instructions. RNase-free water was added to 1 g of isolated total RNA to 
a volume of 41.5 L, and 38.5 L of MasterMix (16 L 5X AMV buffer, 16 L MgCl2, 4 
L dNTP, 1 L RNasin and 0.5 LL of AMV reverse transcriptase) was added to each 
sample. Reactions were incubated at 42°C for 15 minutes and 95°C for 5 minutes in a 
Veriti 96-well thermocycler (Applied Biosystems, Foster City, CA) to form cDNA. 
Intron-spanning equine cytokine-specific primer/probe sets were designed for analysis of 
cDNA of the five cytokines (IL-1 , IL-4, IL-10, TNF- and IFN- ) (Assays-by-Design, 
Applied Biosystems) using real-time PCR (ABI RT-PCR system, Applied Biosystems, 
Foster City, CA) as described in Breathnach et al. (2006). 
Relative quantification of cytokine expression changes were calculated using the 
method, as described by Livak and Schmittgen (2001). Briefly, the cycle 
threshold (CT) values from the real-time PCR instrument are imported into a graphing 
program. The results are normalized to the endogenous control, -glucuronidase 
(Betancourt et al. 2014). The results are given as the mean relative change in cytokine 
gene expression (i.e. gene amplification) in each sample relative to the initial number of 
cDNA molecules in the sample (i.e. RQ value), assumed as proxy for the cytokine levels 
(Livak and Schmittgen 2001).  
3.8. Vaccine ELISAs 
KLH and EHV vaccine ELISAs were performed by Stephanie Reedy (Gluck 
Equine Research Center), and WNV vaccine ELISAs were performed by Dr. Bettina 
Wagner (Cornell University) in order to measure antigen-specific serum antibody levels 
of whole IgG, IgG(a), IgG(b), and IgG(T). The 96-well microtiter plates were coated with 
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300 g of KLH/well or with 50 g of 5 g/mL whole EHV-1 virus/well, and kept at 4°C 
overnight. The sera samples were diluted in order to find the optimal concentration for 
each IgG subtype. The control sera were 2-fold serially diluted to a final concentration of 
7.81 EU/mL. A 1% polyvinyl alcohol (PVA) blocking solution, made in PBS, was diluted 
1:1 with PBS and stored at room temperature until needed. The blocking solution stops 
non-specific binding to the plastic. The secondary antibody was peroxidase-conjugated 
AffiniPure Goat Anti-horse IgG (Jackson Immuno Research, West Grove, PA). When the 
plates were ready, they were washed three times with PBS/TWEEN-20 (PBS-T) and 200 
L of PVA blocking solution was added, and the plates incubated at RT for one hour. The 
plates were washed three more times with PBS-T before 100 L of diluted serum samples 
or standard was added to the appropriate wells in duplicate, and the plates incubated for 
one hour at 37°C. The plates were washed three more times with PBS-T before 100 L of 
secondary antibody was added and incubated for 1 hour at 37°C. The plates were washed, 
and 100 L of SureBlue (KPL, Inc., Gaithersburg, MD) was added to the wells. Stop 
Solution (KPL, Inc., Gaithersburg, MD) was added after 1 minute, and the plate was read 
at 450 nm on a spectrophotometer (BioRad Benchmark Plus). The results were then 
calibrated against the standard curve to determine relative ELISA units (ELISA units/mL) 
(personal communication).  
3.9. Statistical analyses 
Mixed linear model analyses with repeated measures were performed using SAS 
(version 9.3, SAS Institute Inc., Cary, NC, USA) to determine interactions between 
cytokine expression, acute phase markers, vaccine IgGs, and egg counts (Table 4). The 
random effect was the FEC and the class variables were group and time-point; the rest of 
the variables were continuous. Interaction terms were calculated between group and time 
and when time was found significant, a least square means analysis was used for a 
Tukey s pairwise comparison of the time variable. A 5% significance level was used to 
determine those parameters most affected.                  
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4. Results 
4.1. Egg counts 
The average fecal egg count reductions for each group are shown Table 2. A 
negative number in the FECR table means that there was an increase in the levels 
between Day 0 (treatment) and Day 14 in each month. Overall, we saw an average 
efficacy of 96.8% with ivermectin, <1% efficacy with pyrantel, and an average increase 
in egg counts of 13.2% in the control group. 
Table 4.1- The observed efficacies of the two anthelmintics in the study cohort.   
Avg FECR-Aug 
(%) 
Avg FECR-Sept 
(%) 
IVM 100.00 ± 0.00 93.51 ± 17.59 
PYR 53.51 ± 68.89 -55.43 ± 187.68 
Control -25.03 ± 114.39 -1.55 ± 58.31
4.2. Hematology 
As the graphs (Figure 5) indicate, the treatment groups had a 4.28-12% decrease 
in total WBCs, a 2.47-3.25% increase in hematocrit, a 1.13-5.38% increase in 
neutrophils, and a 0.42-3.72% decrease in lymphocytes within the first 5 days after the 
first treatment. In contrast, the control group had a 15.2% decrease in total WBCs, a 
2.51% increase in hematocrit, a 0.43% decrease in neutrophils, and a 1.00% decrease in 
lymphocytes within the first 5 days after the first treatment. The second treatment had 
similar effects to the first, except neutrophil percentages increased. In summary, there 
were negligible changes in all of the hematology over the eight weeks.   
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Figure 4.1- Hematological analysis results. Red= ivermectin; green=pyrantel pamoate; 
blue=control. Error bars are the 95% confidence interval.  
4.3. Inflammatory markers 
As the graphs (Figure 6) indicate, there is a 55.9-133% increase in haptoglobin, a 
21-40.1% increase in fibrinogen, a 2- to 45-fold increase in SAA, and a 4.0-23.9% 
decrease in iron within the first 72 hours after the second treatment. There was a 
statistical difference in the marker levels between the control and treatment groups for 
fibrinogen, but not for SAA, haptoglobin or iron as determined by fixed effects analyses 
(Table 3). 
      
Figure 4.2- Acute phase marker analysis results. Red= ivermectin; green=pyrantel 
pamoate; blue=control. Error bars are the 95% confidence intervals.  
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4.4. Cytokine expression 
With the use of mixed linear analyses and by looking at the graphs (Figure 7), 
there are no statistically significant effects of time on IL-1 , IL-4, IL-10, and TNF- 
levels, but there is a significant statistical and biological decrease in IFN- mRNA levels 
over time, specifically between days 29 and 32. In addition, we see that anthelmintic 
treatment did have a statistically significant effect on the levels of IL-1 and IL-10, but 
not on IL-4, TNF- or IFN- mRNA levels as determined by fixed effects analyses.  
Figure 4.3- Cytokine expression results. Red= ivermectin; green=pyrantel pamoate; 
blue=control. Error bars are the 95% confidence interval. Asterisks signify the timepoints 
at which the groups had significant differences. Double asterisks signify where there was 
a significant difference between timepoints.  
4.5. Vaccine ELISAs 
As seen in the graphs (Figures 8-10), there is an increase in all vaccine antibody 
titers within 14 days post-vaccination, though the largest difference appears to be with the 
WNV IgG(a) between Days 1 and 14, and between days 29 and 42 for KLH IgG(a) and 
IgG(T) titers. The graphical results are consistent with the statistical difference in 
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antibody titers for the three vaccines (Table 3). WNV antibody levels differ significantly 
between days but neither cytokine expression nor inflammatory marker levels had an 
effect. In addition, the IgG(a) levels were numerically higher in the WNV untreated 
control group. KLH antibody levels differed not only between days, but they were also 
affected by SAA, haptoglobin and IFN- levels. On the other hand, treatment did not 
have an effect on the KLH titers. EHV antibody levels differed from day-to-day, but there 
was no effect of treatment, cytokines or inflammatory markers on the EHV antibody 
levels.   
Figure 4.4- EHV vaccine titer ELISA results. Red= ivermectin; green=pyrantel pamoate; 
blue=control. Error bars are the 95% confidence interval. ELISA units are defined as the 
OD ratio (sample OD/cut-off OD). Double asterisks signify where there was a significant 
difference between timepoints.  
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Figure 4.5- WNV vaccine titer ELISA results. Red= ivermectin; green=pyrantel 
pamoate; blue=control. Error bars are the 95% confidence interval. ELISA units are 
defined as the OD ratio (sample OD/cut-off OD). Double asterisks signify where there 
was a significant difference between timepoints.  
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Figure 4.6- KLH vaccine titer ELISA results. Red= ivermectin; green=pyrantel pamoate; 
blue=control. Error bars are the 95% confidence interval. ELISA units are defined as the 
OD ratio (sample OD/cut-off OD). Double asterisks signify where there was a significant 
difference between timepoints.  
Table 4.2- Statistically significant (P 0.05) associations between day, group, 
inflammatory markers and cytokine levels as calculated using a mixed linear model 
analysis. 
Response variable Day/group Inflammatory/immunologic
SAA Day Fibrinogen, TNF-
Haptoglobin Day, Group Iron, Fibrinogen, IL-10, IFN-
Fibrinogen Day, Group SAA, Haptoglobin 
Iron Day Haptoglobin, IL-10, IFN-
IL-1 Group Fibrinogen, Haptoglobin, IL-4, IL-10, TNF-
IL-4 ---- Haptoglobin, IL-10 
IL-10 Group IL-4, IL-1 
IFN- Day Haptoglobin, Iron, IL-10 
TNF- ---- SAA, Fibrinogen, IL-1 
WNV Day ---- 
EHV Day, Group*Day ---- 
KLH Day SAA, Haptoglobin, IFN-
EPG ---- Iron, IL-4, IL-10
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5. Discussion 
There were noteworthy effects of the administration of two different classes of 
anthelmintics on several acute phase markers, cytokines, and vaccine titers. We will 
discuss below those components which responded, both biologically and statistically, to 
the administration of anthelmintics, and those that had little to no response to 
anthelmintic treatment. 
The acute-phase inflammatory marker data showed an increase in SAA, 
haptoglobin, and fibrinogen after each vaccination. At these same time points, the serum 
iron levels decreased, which is consistent with iron sequestration caused by induction of 
inflammation (Wessling-Resnick 2010, Andersen et al. 2012). These results are similar to 
data from Andersen et al. (2012). Their results showed that SAA and fibrinogen 
concentrations increased while those of iron decreased after inflammatory stimulation 
with both ISCOM and live recombinant vaccines (Andersen et al. 2012). In our study we 
administered all three vaccines (KLH, WNV, and EHV) at the same time; even with this 
difference, the results of the Andersen study and ours are similar: the overall trend, as 
expected, is that there is a decrease in iron and an increase in acute phase protein levels. 
Therefore, we can conclude that there was an inflammatory response to vaccination.  
The cytokine expression data shows that anthelmintic treatment did have an effect 
on the immune response to vaccination. In the Edmonds et al. (2001) study, they tested 
whether immunity induced by KLH vaccination would be improved when the parasites 
were removed. Their results were that moxidectin-treated ponies had significantly higher 
levels of IL-4 than those that were treated with pyrantel. With pyrantel administration, the 
ponies had increased IFN- levels as compared to the other groups. Neither IL-5 nor IL-2 
changed with any treatment as compared to the control group. They concluded that the 
decreased immune responses to KLH immunization may model the responses that may be 
seen with other vaccines, meaning that vaccine effectiveness of the vaccines will be 
diminished too (Edmonds et al. 2001). In comparison, our study showed a statistical 
difference between the treatment groups and the control group for IL-1 , another pro-
inflammatory and lymphoproliferative cytokine like IFN- , which suggests that there was 
modulation of the inflammatory response as a result of treatment. Interestingly, there was 
no statistically significant effect of treatment on IFN- or TNF- . Reasons for the 
differences in cytokine expression between this study and Edmonds may be that 1) 
treatment was separated from vaccination in the Edmonds study, 2) we measured gene 
expression by extracting RNA directly from blood, while Edmonds study measured 
cytokine levels after culturing PBMCs, and 3) the Edmonds study removed interaction 
with the acute phase reaction by concentrating on the worm burden effects. As a 
reminder, the Edmonds study set out to assess the effect of increasing numbers of 
gastrointestinal parasites on immune response to vaccination. In addition, we did not 
measure cytokine levels on the golden days of their release, as described in section 
2.6.2. 
The hematology results showed that the percentage of neutrophils increased after 
each treatment. Previous studies involving intestinal inflammation found that 
cyathostomin infection tends to cause short-term neutrophilia due to decreased neutrophil 
turnover (Murphy and Love 1997). The increase in neutrophils is most likely a response 
to vaccination, which we expect, and it is possible that any intestinal reaction to the 
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worms or the treatment was overshadowed by the larger vaccine-associated inflammatory 
response. 
The ELISAs showed that there was no significant difference between treatment 
and control groups, even when taking into consideration the high variability within the 
herd in response to the vaccines. As a side note, it is likely that the ponies were already 
exposed to EHV, because we see a larger increase in antibody levels by Day 1 but not at 
Day 29. The lower KLH IgG titers throughout the study in comparison to the two 
commercial vaccines were likely due to the lack of adjuvant in the protein vaccine and a 
lack of previous exposure. 
The egg count cannot be used as a measure of the number of adult worms in the 
gastrointestinal tract; the accurate enumeration of adult worms is determined at necropsy. 
Though fecal egg counts are inaccurate for enumerating adult worm burdens, the World 
Association for the Advancement of Veterinary Parasitology (WAAVP) recommends this 
method for evaluating anthelmintic efficacy (Coles et al. 1992). It is apparent from the 
FECRT results that the ivermectin treatment was successful against strongyles after both 
Day 0 and Day 29. During this study, the efficacy of pyrantel is diminished after both 
treatment dates, suggesting that there is pyrantel resistance in this study cohort. As a 
consequence of the lack of efficacy, therefore a decreased ability to kill the worms, these 
ponies would most likely have a decreased local inflammatory response. As expected, the 
pyrantel-treated ponies had low egg count reductions and the ivermectin-treated ponies 
had >90% reductions, which is consistent with Lyons et al. (2008), in which they 
reported that on several farms in Central Kentucky, pyrantel was only able to reduce the 
strongyle egg count by an average of 27%, while ivermectin reduced strongyle egg 
counts by 100%.                       
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6. Conclusions  
The overarching conclusion of this study is that deworming does not affect 
vaccine IgG titers, but there is an effect of treatment on vaccine-induced inflammatory 
processes. Therefore, ceasing the practice of vaccinating and deworming on the same day 
does not appear to be necessary at this time. In addition to the effect of deworming on 
vaccine titers, we are able to determine whether ivermectin can act as an anti-
inflammatory; we cannot conclude that ivermectin can act as an anti-inflammatory within 
the parameters of this study, since pyrantel and ivermectin treatments had similar 
biological effects on fibrinogen.                                     
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7. Future studies  
As a follow-up to this study, I would follow Edmonds et al. s model to determine 
the effect of the relative size of the parasite burden on the efficacy of a commercial 
vaccine. In this project, we did not concentrate on the effect the cyathostomins on vaccine 
efficacy, only the effect of the anthelmintics and the inflammatory reaction induced by 
the dying parasites. In the case of the proposed study, I would use EHV because it has 
been proven, not only in this study, but also in other studies, that of the three vaccines 
used in this thesis study, it induces a more significant antibody response in the horse than 
KLH or WNV (Patel et al. 2003, Van de Walle et al. 2010). In addition to the antibody 
response to the vaccine, the inflammatory reaction induced by this vaccine would be an 
increase in IFN- , signifying a pro-inflammatory response that would decrease with the 
presence of the worms (Gildea et al. 2013). I would allocate the horses or ponies into two 
groups: an ivermectin-treated group and an untreated group. Group size is determined 
using G*Power 3.1 analysis software (Faul 2009), with an  of 0.05 and a power of 0.40. 
Using the EHV IgG(a) naïve vaccine titers data for the ivermectin group and the control 
group from this thesis study, I am able to determine that we would need a total of 32 
horses for the study, 16 per group. Pre-treatment and then every week after for three 
weeks, fecals would be taken to determine the anthelmintic efficacy. We should see a 
greater decrease in egg counts in the ivermectin group than the pyrantel group, and the 
control should have the highest EPG. On the same day the horses are dewormed, but 
before all participants receive a dose of EHV vaccine, blood will be taken to determine 
pre-vaccination IgG levels. At two weeks and at one month later, blood would be taken 
again to measure for vaccine-derived antibodies, along with IL-1, IL-10, IFN- , TNF- , 
IL-4, and the acute phase markers (haptoglobin, fibrinogen, SAA, and iron). This study is 
useful because we can determine inflammatory effects for a single vaccine instead of all 
three used in this study, and also, we are concentrating on the effect of the worms rather 
than the treatment. If the parasites do have an effect on vaccine efficacy, then we should 
see an increase in antibody titers with the treatment groups, with the ivermectin-treated 
group having the highest levels of vaccine-derived antibodies.  
We tested the effects of anthelmintics on inflammation in one year old ponies; 
testing the influence of anthelmintics in equids >1 year of age would be logical because 
as horses age, the production of pro-inflammatory cytokines such as IFN- and TNF- 
increase in the peripheral blood (Adams et al. 2008, Hansen et al. 2013). Repeating this 
study in geriatric horses may be beneficial; as horses grow older, the immunological 
reaction to strongyle infection changes, resulting in differences in egg shedding levels 
and the number of cyathostomins found upon necropsy (Chapman et al. 2003, Lyons et 
al. 2012, Wood et al. 2013). In addition, as mentioned earlier in this thesis, the total 
serum IgG decreases and pro-inflammatory cytokine expression increases with age 
(Katepalli et al. 2008).   
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Appendix A: Quantitation of nematode eggs using the mini-FLOTAC method 
We characterized and counted all eggs, but only carried out further quantitation and 
calculations using strongyle egg counts. The mini-FLOTAC method involves the homogenization 
of weighed 5± 0.1 grams of feces in 35±1 mL of flotation solution. The flotation solution was 
made by adding 600 mL of tap water to a 2 liter container. To this was added 250 g of solid NaCl 
(Amresco Corporation, Solon, Ohio) and 375 g of glucose monohydrate (Amresco Corporation, 
Solon, Ohio). Water was then added to 1 L and allowed to stir at 80 degrees C until dissolution, 
and then allowed to cool at room temperature. The resulting solution had a specific gravity equal 
1.25. The mixture of feces and flotation solution in the Fill-FLOTAC was used to fill the two 
flotation chambers (Mini-FLOTAC seen in Figure 2). After 10 ± 2 minutes, the reading disc was 
rotated in order to make a single layer of eggs in each chamber. The two sides of the chamber 
were counted and the eggs per gram were calculated from the sum of the counted eggs by 
multiplying by 5.  
Appendix B: Culturing third-stage strongyle larvae from fecal samples 
Setup of cultures 
Using a modified version of Henriksen and Korsholm (1983), we cultured feces from Day 0 and 
Day 60 in order to characterize the species of strongyles present in the samples. A humidity 
chamber was made to ensure the cultures stayed moist. In order to set up the humidity chamber 
for larval coprocultures, a plastic drinking cup approximately four inches in height was cut two-
thirds of the way from the top. Another cup was filled with 100 mL of water, and the upper part of 
the cut cup was placed in the filled cup. The bottom of the cut cup was pierced with 4-5 holes in 
order to allow air into the culture. An approximately 8 in x 8 in square of cheesecloth was held in 
place to the water-filled cup by the open-ended part of the cut cup. Approximately 5 mL of water 
was added drop-wise to the feces-vermiculite mixture to make a cohesive mass, which was added 
to the cheesecloth. The cheesecloth was folded over the fecal mixture, and the bottom of the cut 
cup with the holes was placed upside down to keep the cheesecloth in place. The cultures were 
allowed to mature at 25°C in an incubator for 14 days, moistening the feces drop-wise directly 
every 2 to 3 days after setup.   
Figure S1. Setup of larval culture in makeshift humidity chamber. 
Picture courtesy of Holli Gravatte.
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Baermannizing 
After 14 days of culturing, the larvae were collected using a modified Baermann 
technique (Olsen et al. 2003). The Baermann technique for harvesting the larvae involves 
attaching the cheesecloth-wrapped culture in its open-ended cup to a tea glass (Libbey Claret 
Footed Iced Tea Glasses, Model # 89594) filled with tap water using large paperclips (Figure 
S2). After the upper part of culture chamber was added to the glass, the cup filled with 100 mL of 
water is scraped to ensure any larvae that have escaped into the water during culturing are added 
to the apparatus. More tap water may have needed to be poured over the cheesecloth-wrapped 
culture until the bottom of the cheesecloth was covered in about a centimeter of water. The 
apparatus was left to sit at room temperature for 24 hours, at which point the cultures were 
removed, and 5 mL of fluid from the bottom of the wineglass was collected in a 15 mL tube, 
which was spun down 1140 x g* for 5 minutes in order to bring all larvae to the bottom.  The 
water was removed with a dropper to a volume of 2 mL and stored at 4°C until the cultures were 
counted using nematode counting slides (Chalex Corporation, Grasonville, MD); the time of 
delay to counting could be immediately after harvest to up to 2 weeks. Prior work in this 
laboratory has determined that the ability of larvae to undergo heating is unchanged at 2 weeks 
post-harvest, as described in Figure S3. 
*conversion factor was found at www.sometechnology.com/pdfFiles/J_6B.pdf 
Larval differentiation  
The harvested, volume-reduced larval solution was mixed using a 5 mL disposable 
transfer pipette in order to make the mixture homogeneous. Then, using the same pipette, the 
entire 2 mL was taken up and added to the nematode slide. The slides were placed on a 55°C 
hotplate for 3 minutes and 30 seconds in order to ensure the larvae were no longer motile. If the 
larvae had continued motility, the slides were heated for an additional 30 seconds. The slides were 
viewed at 10× under a halogen backlit binocular microscope (Nikon Eclipse 80i, Nikon Corp., 
Tokyo, Japan). The third stage larval differentiation was made based on number of intestinal cells, 
presence of a visible cuticle, and shape of the esophagus. Even though there may be first and 
second stage larvae in the culture, we can t differentiate between first or second stage strongyle 
larvae. 
Figure S2. Setup of Baermann apparatus. Picture courtesy of Holli 
Gravatte.  
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Figure S3-Differentiation of larvae grown in coprocultures. Identification is performed according 
to Russell (1948). 
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The larvae were characterized as seen in Table S1; the majority of larvae were found to 
be third stage cyathostomins, identified by their 8 triangular intestinal cells, filariform esophagus, 
sheath, and long tail (Figure 1). In addition, several Poteriostomum spp. and Strongylus vulgaris 
were found using identification parameters defined by Zajac and Conboy (2012), as seen in 
Figure S3. 
Table S1- Larvae characterized in each sample at pre-trial and post-trial dates. 
Pre-trial 
Pony Cyathostomin Poteriostomum S. vulgaris Total % cyathostomins 
M66 55 0 0 55 100.00 
M67 315 0 0 315 100.00 
M69 22 0 0 22 100.00 
M71 86 3 0 89 96.63 
M73 0 0 0 0 100.00 
M74 121 3 0 124 97.58 
M77 981 0 0 981 100.00 
M78 1 13 1 15 6.67 
M79 382 0 0 382 100.00 
M81 388 0 0 388 100.00 
M83 9 0 0 9 100.00 
M85 10 1 0 11 90.91 
M86 131 4 0 135 97.04 
M88 486 0 0 486 100.00 
M90 48 0 0 48 100.00 
M91 106 0 0 106 100.00 
M92 65 0 0 65 100.00 
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Post-trial 
Pony Cyathostomin Poteriostomum S. vulgaris Total % cyathostomins 
M66 107 0 0 107 100.00 
M67 66 0 0 66 100.00 
M69 0 0 0 0 100.00 
M71 7 0 0 7 100.00 
M73 0 0 0 0 100.00 
M74 267 1 0 268 99.63 
M77 303 0 0 303 100.00 
M78 160 0 0 160 100.00 
M79 1 0 0 1 100.00 
M81 229 2 0 231 99.13 
M83 90 0 0 90 100.00 
M85 32 0 0 32 100.00 
M86 2 0 0 2 100.00 
M88 14 0 0 14 100.00 
M90 115 0 0 115 100.00 
M91 29 0 0 29 100.00 
M92 49 0 0 49 100.00 
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Appendix C: Abbreviations 
AMV= avian myeloblastosis virus 
cDNA= complementary DNA 
CT= cycle threshold; proportional to log of the concentration 
CTRL= control 
EHV= equine herpes rhinopneumonitis virus 
epg= eggs per gram of feces 
FEC= fecal nematode egg count 
FECRT= fecal nematode egg count reduction test 
GABA= gamma-aminobutyric acid 
IFN- = interferon-gamma 
IgG= immunoglobulin G 
IL-1= interleukin 1 
IL-4= interleukin 1 
IL-10= interleukin 10 
ISCOM= Immune Stimulating COMplex 
IVM= ivermectin 
KLH= keyhole limpet hemocyanin 
L1= first larval stage 
L2= second larval stage 
L3= third larval stage; infective stage; on pasture 
EL3= early third larval stage; in horse large intestine 
LL3= late third larval stage; in horse large intestine 
L4= fourth larval stage 
L5= early fifth stage (adult) 
nACh= nicotinic acetylcholine 
NFR= NADH-fumerate reductase 
PBMC= peripheral blood mononuclear cell 
PYR= pyrantel pamoate 
SAA= serum amyloid A 
Th1= type 1 helper T-cell 
Th2= type 2 helper T-cell  
TNF- = tumor necrosis factor alpha
WNV= West Nile virus            
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